BIOVF
Price
$30.75
Change
+$1.78 (+6.14%)
Updated
Aug 22 closing price
Capitalization
10.4B
INNPF
Price
$0.15
Change
-$0.00 (-0.00%)
Updated
Aug 15 closing price
Capitalization
36.56M
Interact to see
Advertisement

BIOVF vs INNPF

Header iconBIOVF vs INNPF Comparison
Open Charts BIOVF vs INNPFBanner chart's image
Swedish Orphan Biovitrum AB
Price$30.75
Change+$1.78 (+6.14%)
Volume$243
Capitalization10.4B
Innocan Pharma
Price$0.15
Change-$0.00 (-0.00%)
Volume$7.44K
Capitalization36.56M
BIOVF vs INNPF Comparison Chart in %
Loading...
BIOVF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INNPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIOVF vs. INNPF commentary
Aug 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIOVF is a StrongBuy and INNPF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 28, 2025
Stock price -- (BIOVF: $30.75 vs. INNPF: $20.01)
Brand notoriety: BIOVF and INNPF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: BIOVF: 80% vs. INNPF: 73%
Market capitalization -- BIOVF: $10.4B vs. INNPF: $36.56M
BIOVF [@Pharmaceuticals: Generic] is valued at $10.4B. INNPF’s [@Pharmaceuticals: Generic] market capitalization is $36.56M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.86B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIOVF’s FA Score shows that 0 FA rating(s) are green whileINNPF’s FA Score has 1 green FA rating(s).

  • BIOVF’s FA Score: 0 green, 5 red.
  • INNPF’s FA Score: 1 green, 4 red.
According to our system of comparison, INNPF is a better buy in the long-term than BIOVF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIOVF’s TA Score shows that 5 TA indicator(s) are bullish while INNPF’s TA Score has 7 bullish TA indicator(s).

  • BIOVF’s TA Score: 5 bullish, 3 bearish.
  • INNPF’s TA Score: 7 bullish, 2 bearish.
According to our system of comparison, INNPF is a better buy in the short-term than BIOVF.

Price Growth

BIOVF (@Pharmaceuticals: Generic) experienced а +6.14% price change this week, while INNPF (@Pharmaceuticals: Generic) price change was +3.41% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.79%. For the same industry, the average monthly price growth was +11.19%, and the average quarterly price growth was +81.73%.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.79% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BIOVF($10.4B) has a higher market cap than INNPF($36.6M). BIOVF YTD gains are higher at: 11.171 vs. INNPF (6.545). BIOVF has higher annual earnings (EBITDA): 9.77B vs. INNPF (219M). BIOVF has more cash in the bank: 1.06B vs. INNPF (5.01M). INNPF has less debt than BIOVF: INNPF (1.44B) vs BIOVF (12.8B). BIOVF has higher revenues than INNPF: BIOVF (27B) vs INNPF (727M).
BIOVFINNPFBIOVF / INNPF
Capitalization10.4B36.6M28,415%
EBITDA9.77B219M4,462%
Gain YTD11.1716.545171%
P/E Ratio23.39N/A-
Revenue27B727M3,714%
Total Cash1.06B5.01M21,126%
Total Debt12.8B1.44B888%
FUNDAMENTALS RATINGS
BIOVF: Fundamental Ratings
BIOVF
OUTLOOK RATING
1..100
94
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
47
SMR RATING
1..100
65
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
92
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BIOVFINNPF
RSI
ODDS (%)
Bearish Trend 3 days ago
61%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
60%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 3 days ago
41%
Bullish Trend 1 day ago
60%
MACD
ODDS (%)
Bullish Trend 3 days ago
51%
Bullish Trend 1 day ago
52%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
47%
Bullish Trend 1 day ago
46%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
44%
Bullish Trend 1 day ago
43%
Advances
ODDS (%)
N/A
Bullish Trend 7 days ago
48%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
43%
Bullish Trend 1 day ago
61%
Aroon
ODDS (%)
Bullish Trend 3 days ago
58%
Bullish Trend 1 day ago
44%
View a ticker or compare two or three
Interact to see
Advertisement
BIOVF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INNPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FRMO8.990.04
+0.45%
FRMO Corp.
SKKY0.67N/A
N/A
Skkynet Cloud Systems Inc.
OAOFY9.55N/A
N/A
PJSC Tatneft
ICTEF8.13-0.42
-4.91%
International Container Terminal Services, Inc.
ROIUF0.04-0.01
-22.05%
Route1 Inc.

BIOVF and

Correlation & Price change

A.I.dvisor tells us that BIOVF and INNPF have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BIOVF and INNPF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIOVF
1D Price
Change %
BIOVF100%
N/A
INNPF - BIOVF
20%
Poorly correlated
+0.25%
APNHY - BIOVF
19%
Poorly correlated
+7.75%
BIOGY - BIOVF
11%
Poorly correlated
N/A
BOIRF - BIOVF
1%
Poorly correlated
N/A
ARSUF - BIOVF
1%
Poorly correlated
N/A
More

INNPF and

Correlation & Price change

A.I.dvisor tells us that INNPF and HYEX have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INNPF and HYEX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INNPF
1D Price
Change %
INNPF100%
+0.25%
HYEX - INNPF
20%
Poorly correlated
-7.46%
APNHF - INNPF
20%
Poorly correlated
N/A
BIOVF - INNPF
20%
Poorly correlated
N/A
KKPCF - INNPF
6%
Poorly correlated
N/A
VEXTF - INNPF
6%
Poorly correlated
-0.78%
More